Work led by Phoenix-based TGen has concluded that research on multiple myeloma — a blood cancer — has focused very little on African-American men, who are much more likely to be diagnosed with it. A high percentage of the research has been based on people of European origin.
To learn more about why the research has been conducted this way and how to improve it, we turn to Dr. Jonathan Keats. He’s the head of the Multiple Myeloma Research Laboratory at TGen.
